AMERIPRISE FINANCIAL INC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$245,345
+281.5%
284,327
+1093.8%
0.00%
Q2 2023$64,305
-86.0%
23,817
-3.6%
0.00%
Q1 2023$460,921
+3.6%
24,701
-11.0%
0.00%
Q4 2022$445,000
+23.6%
27,746
+0.3%
0.00%
Q3 2022$360,000
+19.6%
27,666
-6.0%
0.00%
Q3 2021$301,000
-76.8%
29,428
-39.5%
0.00%
Q2 2021$1,295,000
-45.4%
48,640
-28.9%
0.00%
-100.0%
Q1 2021$2,373,000
-13.0%
68,367
-7.1%
0.00%0.0%
Q4 2020$2,729,000
-11.5%
73,618
-1.8%
0.00%0.0%
Q3 2020$3,084,000
-17.0%
74,991
-18.2%
0.00%
-50.0%
Q2 2020$3,714,000
-7.0%
91,638
-20.2%
0.00%0.0%
Q1 2020$3,993,000
-11.9%
114,847
+8.7%
0.00%0.0%
Q4 2019$4,534,000
+19.6%
105,702
+3.1%
0.00%0.0%
Q3 2019$3,790,000
-24.1%
102,498
-7.3%
0.00%0.0%
Q2 2019$4,994,000
-41.3%
110,519
-29.4%
0.00%
-50.0%
Q1 2019$8,514,000
+408.9%
156,651
+333.4%
0.00%
+300.0%
Q4 2018$1,673,000
-51.7%
36,148
-36.6%
0.00%0.0%
Q3 2018$3,466,000
+6.5%
57,049
+9.7%
0.00%0.0%
Q2 2018$3,255,000
+169.0%
51,996
+98.5%
0.00%0.0%
Q1 2018$1,210,000
-3.6%
26,192
-1.1%
0.00%0.0%
Q4 2017$1,255,000
-30.2%
26,477
-20.7%
0.00%0.0%
Q3 2017$1,797,000
+15.6%
33,391
-54.3%
0.00%0.0%
Q1 2016$1,555,000
-35.2%
73,037
-7.3%
0.00%0.0%
Q4 2015$2,401,000
+70.4%
78,787
+22.5%
0.00%0.0%
Q3 2015$1,409,00064,2930.00%
Other shareholders
FIBROGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders